Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Monro
MNRO
$398M
| $27.2M | 0.01% |
494,825
+12,671
| +3% | +$674K |
|
1277
10x Genomics
TXG
$5.85B
| $27.2M | 0.01% |
304,185
+198,559
| +188% | +$15.5M |
|
1278
Atlantic Union Bankshares
AUB
$5.97B
| $27M | 0.01% |
1,166,627
-15,720
| -1% | -$354K |
|
1279
Ligand Pharmaceuticals
LGND
$5.93B
| $26.9M | 0.01% |
386,135
-30,361
| -7% | -$1.92M |
|
|
PPBI
1280
DELISTED
Pacific Premier Bancorp
PPBI
| $26.9M | 0.01% |
1,241,750
+363,922
| +41% | +$7.3M |
|
|
DCPH
1281
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $26.9M | 0.01% |
450,768
+114,990
| +34% | +$6.15M |
|
1282
Acadia Healthcare
ACHC
$2.89B
| $26.9M | 0.01% |
1,069,032
-1,049
| -0.1% | -$26.2K |
|
1283
Element Solutions
ESI
$9.36B
| $26.8M | 0.01% |
2,467,284
+31,055
| +1% | +$312K |
|
|
UNIT
1284
Uniti Group
UNIT
$2.31B
| $26.7M | 0.01% |
2,860,668
+80,417
| +3% | +$603K |
|
|
PINC
1285
DELISTED
Premier
PINC
| $26.7M | 0.01% |
777,470
-1,780
| -0.2% | -$58.5K |
|
|
DOOR
1286
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $26.6M | 0.01% |
341,975
-565
| -0.2% | -$34.3K |
|
1287
Bankunited
BKU
$3.37B
| $26.6M | 0.01% |
1,312,445
+273,311
| +26% | +$5.12M |
|
|
GTLS
1288
DELISTED
Chart Industries
GTLS
| $26.6M | 0.01% |
547,632
+24,374
| +5% | +$893K |
|
|
MGLN
1289
DELISTED
Magellan Health Services, Inc.
MGLN
| $26.5M | 0.01% |
363,392
+19,681
| +6% | +$1.26M |
|
|
CVET
1290
DELISTED
Covetrus, Inc. Common Stock
CVET
| $26.4M | 0.01% |
1,478,424
+292,800
| +25% | +$3.85M |
|
1291
PRA Group
PRAA
$780M
| $26.4M | 0.01% |
683,508
+18,332
| +3% | +$581K |
|
1292
InterDigital
IDCC
$8.8B
| $26.4M | 0.01% |
465,923
-1,600
| -0.3% | -$85.1K |
|
|
SUM
1293
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $26.4M | 0.01% |
1,668,743
+63,842
| +4% | +$916K |
|
1294
Howard Hughes
HHH
$4.07B
| $26.4M | 0.01% |
532,642
+21,458
| +4% | +$1.08M |
|
1295
News Corp Class B
NWS
$18B
| $26.4M | 0.01% |
2,207,566
+58,254
| +3% | +$631K |
|
1296
Editas Medicine
EDIT
$455M
| $26.3M | 0.01% |
889,679
+105,111
| +13% | +$2.75M |
|
1297
Shake Shack
SHAK
$2.86B
| $26.3M | 0.01% |
496,517
+80,827
| +19% | +$4.09M |
|
|
LVGO
1298
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $26.3M | 0.01% |
349,421
-128,670
| -27% | -$6.73M |
|
1299
Restaurant Brands International
QSR
$25.5B
| $26.2M | 0.01% |
481,681
+34,803
| +8% | +$1.76M |
|
|
CHX
1300
DELISTED
ChampionX
CHX
| $26.2M | 0.01% |
2,680,952
+1,799,618
| +204% | +$16.5M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.